Cationic copolymers nanoparticles for nonviral gene vectors: Synthesis, characterization, and application in gene delivery
Source abstract
Abstract
Abstract The major aim of nonviral delivery systems for gene therapy is to mediate high levels of gene expression with low toxicity. Nowadays, one of the most successful synthetic polycations used in gene delivery research is poly(ethylenimine) (PEI) in its high‐molecular weight (HMW) branched form. However, PEI is not the ideal transfection agent in vivo because of its overwhelming cytotoxicity. To overcome its toxic effects with a minimal impact on transfection efficiency, PEI has been conjugated with several nonionic biocompatible polymers. Here, we describe the synthesis of nanosized particles consisting of HMW PEI (25 kDa) crosslinked with poly(ε‐caprolactone) (PCL, 50–60 kDa), a biodegradable aliphatic polyester. PCL was modified by the insertion of glycidyl groups able to condense with the amines of PEI to chemically bind PEI onto PCL. The nanoparticles obtained have been characterized in relation to their physicochemical and biological properties, and the results are extremely promising in terms of low cell toxicity and high transfection efficiency. These biological effects might be related to the peculiar DNA binding to covalently connected polymeric nanoparticles, without the formation of entangled DNA/polymer‐soluble aggregates. © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2010
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. 10.1016/j.biomaterials.2005.09.03610.1016/j.biomaterials.2005.09.036 ↗
2. 10.1016/S0378-5173(01)00861-410.1016/S0378-5173(01)00861-4 ↗
3. 10.1016/S0169-409X(01)00202-210.1016/S0169-409X(01)00202-2 ↗
4. 10.1016/S0168-3659(99)00090-510.1016/S0168-3659(99)00090-5 ↗
5. 10.1021/ma012060a10.1021/ma012060a ↗
6. 10.1021/bc049847110.1021/bc0498471 ↗
7. 10.1016/j.biomaterials.2006.09.02810.1016/j.biomaterials.2006.09.028 ↗
8. 10.1016/j.jconrel.2005.02.00410.1016/j.jconrel.2005.02.004 ↗
9. 10.1016/j.ijpharm.2005.04.01710.1016/j.ijpharm.2005.04.017 ↗
10. 10.1016/S0168-3659(99)00151-010.1016/S0168-3659(99)00151-0 ↗
11. 10.1016/S0168-3659(02)00371-110.1016/S0168-3659(02)00371-1 ↗
12. 10.1016/S0168-3659(03)00302-X10.1016/S0168-3659(03)00302-X ↗
13. 10.1016/j.biomaterials.2003.08.06910.1016/j.biomaterials.2003.08.069 ↗
14. 10.1021/bc970130610.1021/bc9701306 ↗
15. 10.1093/jnci/82.13.110710.1093/jnci/82.13.1107 ↗
16. 10.1016/S0378-5173(01)00923-110.1016/S0378-5173(01)00923-1 ↗
17. 10.1016/S0032-3861(01)00013-110.1016/S0032-3861(01)00013-1 ↗
18. 10.1002/jbm.a.3115010.1002/jbm.a.31150 ↗
19. 10.1016/S0032-3861(00)00253-610.1016/S0032-3861(00)00253-6 ↗
20. 10.1016/S0032-3861(01)00673-510.1016/S0032-3861(01)00673-5 ↗
21. 10.1016/S0168-3659(00)00317-510.1016/S0168-3659(00)00317-5 ↗
22. 10.1002/app.1981.07026112410.1002/app.1981.070261124 ↗
23. 10.1002/pola.2071810.1002/pola.20718 ↗
24. 10.1209/0295-5075/84/2600610.1209/0295-5075/84/26006 ↗
25. 10.1016/0142-9612(96)00049-X10.1016/0142-9612(96)00049-X ↗
26. 10.1023/A:101212630129010.1023/A:1012126301290 ↗
27. 10.1023/A:100754882649510.1023/A:1007548826495 ↗
28. Crosslinked polyethylenimine.hexamethaphosphate nanoparticles to deliver nucleic acids therapeutics
29. 10.1007/s12272-008-1126-510.1007/s12272-008-1126-5 ↗
30. Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles